Target directed enediyne prodrugs: Cytotoxic estrogen conjugates

被引:26
作者
Jones, GB [1 ]
Huber, RS [1 ]
Mathews, JE [1 ]
Li, AW [1 ]
机构
[1] CLEMSON UNIV,BIOMED COOPERAT,GREENVILLE HOSP SYST,CLEMSON,SC 29634
关键词
D O I
10.1016/0040-4039(96)00662-4
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Enediyne estrogen conjugates have been prepared from readily available precursors. Enediyne 12 causes significant DNA strand scission at 10(-3) M, and has demonstrated cytotoxicity against the ER rich MCF-7 human breast cancer cell line. Copyright (C) 1996 Elsevier Science Ltd.
引用
收藏
页码:3643 / 3646
页数:4
相关论文
共 16 条
[1]  
BOWLER J, 1989, Steroids, V54, P71, DOI 10.1016/0039-128X(89)90076-7
[2]   11-BETA-AMIDOALKYL ESTRADIOLS, A NEW SERIES OF PURE ANTIESTROGENS [J].
CLAUSSNER, A ;
NEDELEC, L ;
NIQUE, F ;
PHILIBERT, D ;
TEUTSCH, G ;
VANDEVELDE, P .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 41 (3-8) :609-614
[3]   TOWARDS ENEDIYNE LIBRARIES - CYCLIC ENEDIYNES VIA AN INTRAMOLECULAR CARBENOID COUPLING PROTOCOL [J].
JONES, GB ;
HUBER, RS ;
MATHEWS, JE .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1995, (17) :1791-1792
[4]  
JONES GB, 1994, TETRAHEDRON LETT, V35, P2655
[5]  
JONES GB, Patent No. 5436361
[6]  
KATZZENELLENBOG.JA, 1991, P RA WELCH F CHEM FR, V35, P229
[7]   SYNTHESIS OF STEROIDAL NITROSOUREAS WITH ANTI-TUMOR ACTIVITY [J].
LAM, HYP ;
BEGLEITER, A ;
GOLDENBERG, GJ ;
WONG, CM .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (02) :200-202
[8]   NOVEL ACRIDINE-TRIAZENES AS PROTOTYPE COMBILEXINS - SYNTHESIS, DNA-BINDING, AND BIOLOGICAL-ACTIVITY [J].
MCCONNAUGHIE, AW ;
JENKINS, TC .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (18) :3488-3501
[9]   CHEMISTRY AND BIOLOGY OF THE ENEDIYNE ANTICANCER ANTIBIOTICS [J].
NICOLAOU, KC ;
DAI, WM .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1991, 30 (11) :1387-1416
[10]   CHEMISTRY AND BIOLOGY OF NATURAL AND DESIGNED ENEDIYNES [J].
NICOLAOU, KC ;
SMITH, AL ;
YUE, EW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5881-5888